You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

The Role of High Dose Rate Brachytherapy in the Palliation of Symptom in Patients with Non-Small Cell Lung Cancer

Version: 3 ID: 7-16 Jun 2018
Type of Content: Guidelines & Advice, Clinical
Document Status: Current
Lung Cancer Disease Site Group

Patient Population

Adult patients with symptomatic endobronchial disease in non-small cell lung cancer.

Research Question(s)

  1. Is there a role for high dose rate endobronchial brachytherapy (HDREB) in the palliation of respiratory symptoms in patients with non-small cell lung cancer?
  2. If so, what is the optimal dose of HDREB in this setting?
pdf download Summary (PDF) (175.2 KB)